All lobbying filings

DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)

Lobbying for DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.) · Biopharmaceutical organization developing medicines for disorders of the brain.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $90,000.00 expenses · posted Jan 20, 2026

Official filing document

Lobbying activity 1

Health Issues

Lack of innovation in mental health. Need for more efficient communication/collaboration between FDA/DEA and need for VA to operationalize itself for when new therapies are approved by the FDA and rescheduled by the DEA.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.